NDC 63304-211-11 - Glycopyrrolate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63304-211
- Requested NDC
- 63304-211-11
- Package NDCs from labels
- 63304-211-30, 63304-211-01, 63304-211-10, 63304-211-11, 63304-211-69
- Manufacturer
- Ranbaxy Pharmaceuticals Inc. | Ohm Laboratories Inc.
- Effective date
- 2013-01-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYCOPYRROLATE TABLETS, USP Rx only | Ranbaxy Pharmaceuticals Inc. | Ohm Laboratories Inc. | 2013-01-03 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63304-211-01 | Glycopyrrolate | 100 in 1 BOTTLE | TABLET | 100 | 3 | |
| 63304-211-10 | Glycopyrrolate | 1000 in 1 BOTTLE | TABLET | 1000 | 3 | |
| 63304-211-11 | Glycopyrrolate | 10 in 1 BLISTER PACK | TABLET | 10 | 3 | |
| 63304-211-30 | Glycopyrrolate | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 63304-211-69 | Glycopyrrolate | 1 in 1 BOX | TABLET | 1 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.] | 3 | |
| GLYCOPYRRONIUM | ACTIVE MOIETY | A14FB57V1D | GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.] | 3 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.] | 3 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.] | 3 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLYCOPYRROLATE | GLYCOPYRROLATE | American Health Packaging | 6404fc8e-d109-4950-9dca-c8a85ad90cf3 | 2025-05-18 | Warnings, Adverse reactions | 197738 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Leading Pharma, LLC | 498bce66-6072-4212-8413-ff9888c58f9c | 2025-04-25 | Warnings, Adverse reactions | 197739 197738 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Chartwell RX, LLC | 89090b34-470c-478c-be49-1d2bc48a28f8 | 2025-04-17 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Aurobindo Pharma Limited | 4b3f8b3e-6fa8-471b-8bee-3dac5e3ea1b8 | 2025-04-17 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | AvPAK | bd497783-e2d1-130c-e053-2995a90a7fb9 | 2025-03-04 | Warnings, Adverse reactions | 197738 V92SO9WP2I |
| Walgreens Soothing Eye Relief Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Walgreens Co. | 29b7387b-ad65-3a11-e063-6394a90a6a15 | 2025-02-14 | Warnings | FZ989GH94E |
| Glycopyrrolate | GLYCOPYRROLATE | Caplin Steriles Limited | 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2025-01-25 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9a3a142c-daaf-79af-e053-2995a90a1c51 | 2025-01-08 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9bde90dd-0300-f705-e053-2a95a90a7ea6 | 2025-01-08 | Warnings, Adverse reactions | V92SO9WP2I |
| Cuvposa | GLYCOPYRROLATE | Merz Pharmaceuticals, LLC | d200bd44-9856-4104-a29e-a4cca3db6737 | 2024-12-19 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 5ee5f433-fd99-4c8d-8263-b8956d489620 | 2024-12-12 | Warnings, Adverse reactions | 197738 V92SO9WP2I |
| glycopyrrolate | GLYCOPYRROLATE | Saptalis Pharmaceuticals, LLC. | 3e6f8091-d6fe-4c8f-b897-606a70bf74bc | 2024-11-12 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | ccafb5c2-86dd-4bb2-883a-c13e3171227c | 2024-10-14 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Somerset Therapeutics, LLC | 48cfbd5a-b133-4720-9bd7-65296064ea3c | 2024-08-31 | Warnings, Adverse reactions | V92SO9WP2I |
| Artificial Tears | POLYVINYL ALCOHOL, POVIDONE | NuCare Pharmaceuticals,Inc. | 9c1c4911-908e-3c3c-e053-2995a90abcfc | 2024-06-14 | Warnings | FZ989GH94E |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | bfccdb26-5047-4b54-9732-ffac2d78e4d1 | 2024-05-29 | Warnings, Adverse reactions | 197738 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 685aaf64-1a64-42f9-a96f-4764d650c26f | 2024-05-14 | Warnings, Adverse reactions | V92SO9WP2I |
| PREVDUO | NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE | Endo USA | dd8ad38f-247b-4948-a13c-8f3a4921b4f1 | 2024-04-10 | Warnings, Adverse reactions | V92SO9WP2I |
| Clear Eyes Natural Tears | POLYVINYL ALCOHOL AND POVIDONE | Prestige Brands Holdings, Inc. | efba3eb0-798d-4635-b19b-4970e45b3cc9 | 2024-04-01 | Warnings | FZ989GH94E |
| REFRESH CLASSIC | POLYVINYL ALCOHOL, POVIDONE | A-S Medication Solutions | 3bf6193c-56db-45ad-844c-58eb8c33cba9 | 2024-03-14 | Warnings | FZ989GH94E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.